Navin Fluorine International: Business Overview & Financial Analysis
Navin Fluorine International Limited is an Indian specialty fluorochemicals manufacturing enterprise headquartered in Mumbai, Maharashtra. Promoted by the Padmanabh Mafatlal Group, the company operates one of India's largest integrated fluorochemical complexes across Surat and Dahej in Gujarat, alongside a Contract Development and Manufacturing Organization (CDMO) facility in Dewas, Madhya Pradesh. Navin Fluorine International manufactures hydrofluoric acid, specialty fluorinated intermediates, inorganic fluorides, hydrofluoroolefins (HFO), and refrigerant gases servicing life sciences, crop protection, stainless steel, electronics, and automotive sectors globally.
Business Vertical Revenue Breakdown of Navin Fluorine International (FY26)
Navin Fluorine International derives its operational revenue across three primary business divisions centered on fluorine chemistry.
- High Performance Products (HPP) – ~41.0% of Total Revenue
- Specialty Chemicals Division – ~41.0% of Total Revenue
- Contract Development & Manufacturing Organization (CDMO) – ~18.0% of Total Revenue
The High Performance Products (HPP) division provides refrigerant gases, anhydrous hydrofluoric acid (AHF), and industrial fluorides. Specialty Chemicals supplies complex fluorinated building blocks to crop science and pharmaceutical innovators, while the CDMO division handles clinical-stage synthesis and active pharmaceutical ingredient (API) commercialization.
Geographic & Export Revenue Mix of Navin Fluorine International (FY26)
Navin Fluorine International distributes its product range across international regulated markets and domestic industrial sectors.
- Export Market Share – ~58.0% of Total Revenue
- India (Domestic Market Share) – ~42.0% of Total Revenue
- Key Export Destinations – North America, Europe, Japan, and Asia-Pacific
International markets contribute nearly three-fifths of corporate turnover, driven by custom synthesis contracts and long-term supply agreements for low Global Warming Potential (GWP) refrigerant gases. The domestic business supplies stainless steel, glass, and agrochemical manufacturers across India.
Product Capabilities & Manufacturing Infrastructure of Navin Fluorine International (FY26)
Navin Fluorine International operates three integrated manufacturing complexes across Gujarat and Madhya Pradesh.
- Surat Complex (Gujarat) – Dedicated to refrigerants, AHF, inorganic fluorides, and R32 gases
- Dahej Complex (Gujarat) – Multi-Purpose Plant (MPP) for fluoro-specialty chemicals and HFO products
- Dewas Complex (Madhya Pradesh) – Dedicated cGMP-compliant CDMO research and production facility
- Captive AHF Plant Capacity – Expanded to support internal fluorination requirements
The manufacturing infrastructure supports complex fluorination capabilities including gas-phase, liquid-phase, halogen exchange, and continuous process chemistry. In-house AHF production provides backward integration for specialty chemical and CDMO operations.
Contract Development & Manufacturing Organization (CDMO) Operations of Navin Fluorine International (FY26)
Navin Fluorine International offers chemical development and early-stage synthesis services to global life sciences companies.
- Division Annual Revenue Growth – +61% YoY in Q4 FY26 (Rs 186 crore)
- Key Infrastructure Assets – cGMP-compliant research labs and manufacturing blocks
- Primary Client Base – European and US pharmaceutical innovators
- Active Pipeline Commercializations – cGMP4 facility expansion under execution
The CDMO business serves as a high-margin growth engine, advancing molecules from early clinical phases through to commercial API supply. Sourcing relationships with European pharma majors maintain high visibility for upcoming clinical campaign dispatches.
Latest Quarterly Financial Performance of Navin Fluorine International (Q4 FY26)
Navin Fluorine International delivered top-line revenue expansion and net profit growth in the fourth quarter of FY26.
- Consolidated Revenue from Operations – Rs 937.71 crore (+33.8% YoY / +5.1% QoQ)
- Operating EBITDA – Rs 321.15 crore (+79.7% YoY)
- Operating EBITDA Margin – 34.2% (+875 bps YoY)
- Consolidated Net Profit After Tax (PAT) – Rs 212.62 crore (+123.9% YoY)
- Board Recommended Final Dividend – Rs 8.60 per equity share (430% of face value)
Fourth-quarter operating revenue rose 33.8% year-on-year to Rs 937.71 crore, supported by a 61% surge in CDMO revenue and 39% growth in Specialty Chemicals. Consolidated Net Profit After Tax grew 123.9% to Rs 212.62 crore as EBITDA margins expanded to 34.2% due to operational leverage and product mix enrichment.
Consolidated Annual Financial Performance of Navin Fluorine International (FY26)
Navin Fluorine International reported record operating revenue and profit expansion for full financial year FY26.
- Full Year Revenue from Operations – Rs 3,313.90 crore (+41.1% YoY)
- Full Year Operating EBITDA – Rs 1,081.68 crore (+102.7% YoY)
- Full Year Operating EBITDA Margin – 32.6% (+992 bps YoY)
- Full Year Consolidated Net Profit After Tax (PAT) – Rs 663.56 crore (+129.9% YoY)
Full-year operating revenue crossed the Rs 3,300 crore mark in FY26, propelled by broad-based volume recovery across specialty chemicals and refrigerant lines. Operating EBITDA more than doubled to Rs 1,081.68 crore, expanding margins by 992 basis points.
Key Balance Sheet Metrics & Return Ratios of Navin Fluorine International (FY26)
Navin Fluorine International maintains balance sheet stability while executing capital expenditure programs.
- Net Debt to Equity Ratio – 0.28x
- Operating Cash Flow – >Rs 700 crore
- Return on Capital Employed (ROCE) – ~18.0%
- Return on Equity (ROE) – ~17.5%
Operating cash flows supported working capital management and capital expansion projects. Financial leverage remained controlled, sustaining a low Net Debt to Equity ratio of 0.28x.
Capex Pipeline & Expansion Roadmap of Navin Fluorine International (FY27–FY28)
Navin Fluorine International executes capital deployment outlays to debottleneck facilities and expand hydrofluoroolefin (HFO) production.
- R32 Refrigerant Gas Capacity Expansion – Rs 236.5 crore outlay (15,000 MTPA addition; Commissioning: Q3 FY27)
- Dahej Multi-Purpose Plant (MPP) Debottlenecking – Target commissioning in Q3 FY27
- cGMP4 Facility Expansion (Dewas) – Rs 288 crore project outlay
- Chemours Hydrofluoroolefin (HFO) Supply Partnership – Project completion targeted for H1 FY27
- Funding Method – Internal cash accruals and debt facilities
The company is deploying capital across its Surat, Dahej, and Dewas units to scale R32 gas output by 15,000 MTPA and complete the Chemours supply project. These projects position the business to capture rising global demand for next-generation low-GWP gases.
Management Commentary & Strategic Outlook of Navin Fluorine International (Q4 FY26)
Management guidance outlines strategic priorities centered on completing capex projects, scaling CDMO contracts, and preserving operating margins.
- Management projects sustained double-digit top-line revenue growth during FY27, backed by multi-year specialty chemical contracts.
- Operating EBITDA margins are guided to remain within the 30%–33% band through operating leverage and high-margin product dispatches.
- R32 refrigerant gas capacity addition of 15,000 MTPA will be commissioned by Q3 FY27 to serve domestic and export room air conditioner (RAC) demand.
- Specialty Chemicals division growth will be supported by commercializing new molecules from the Dahej MPP facility.
- CDMO operations will focus on executing cGMP4 capacity additions and onboarding late-stage clinical phase programs.
Management anticipates strong global demand for fluorinated solutions across life sciences and cooling applications. Operational priorities center on executing the Rs 236.5 crore R32 project, commissioning the Chemours partnership line, and deepening R&D capabilities in fluorospecialty chemistry.
Want to filter out stocks using your own financial benchmarks? You can use the Stock Screener on Finology Ticker to identify and compare companies based on specific growth and efficiency metrics.
Sources & References
- Navin Fluorine International Limited Q4 & Full Year FY26 Consolidated Financial Results Disclosures (April 2026)
- Navin Fluorine International Limited Q4 FY26 Earnings Conference Call Transcript (April 2026)
- Navin Fluorine International Limited Q4 & FY26 Investor Presentation (April 2026)
- BSE India & NSE Official Corporate Announcements for Navin Fluorine International Limited
- Ticker Finology Navin Fluorine Page
Disclaimer
The information presented above on Navin Fluorine International Limited has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Navin Fluorine International Limited page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.